Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05288348 · ClinicalTrials.gov registry record · Phase 3
DSUVIA Early Evaluation of Pain Trial
A Phase 3 study of Traumatic Injury, sponsored by Frank Guyette.
- Completed
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05288348: Completed Phase 3 study of Traumatic Injury, sponsored by Frank Guyette.
NCT05288348 is a Phase 3 study of Traumatic Injury that has completed, run by Frank Guyette. The registered enrollment target is 150 participants, below the 418-participant average among 7 other Traumatic Injury trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05288348, a Phase 3 study of Traumatic Injury, has completed, sponsored by Frank Guyette.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized, interventional trial of Emergency Department (ED) administration of DSUVIA (sufentanil) versus standard care pain management comparing pain treatment outcomes in injured patients with moderate to severe pain
Primary Outcome
Verbally administered Numeric Rating Scale (VNRS) for clinical pain measurement (scale of 0-100, where 0 is having no pain)
Conditions Studied
Interventions
- DRUG Sufentanil 30 MCG Sublingual Tablet
- DRUG standard care pain treatment
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-08-05 |
| Est. Completion | 2024-01-21 |
| Phase | Phase 3 |
What the finished NCT05288348 record still lists
NCT05288348 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 418-participant average among 7 other Traumatic Injury trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Traumatic Injury appearing as the primary indexed condition, and to 2 interventions - of which Sufentanil 30 MCG Sublingual Tablet is the first listed.
NCT05288348 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05288348 about?
NCT05288348 is a clinical study titled "DSUVIA Early Evaluation of Pain Trial". Randomized, interventional trial of Emergency Department (ED) administration of DSUVIA (sufentanil) versus standard care pain management comparing pain treatment outcomes in injured patients with moderate to severe pain
What is the current status of trial NCT05288348?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2022-08-05. Estimated completion is 2024-01-21.
What conditions does trial NCT05288348 study?
This clinical trial studies the following conditions: Traumatic Injury.
What interventions are being tested in trial NCT05288348?
The interventions under investigation include: Sufentanil 30 MCG Sublingual Tablet (DRUG), standard care pain treatment (DRUG).
Who is sponsoring clinical trial NCT05288348?
This trial is sponsored by Frank Guyette, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05288348 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prehospital Analgesia INtervention Trial (PAIN)
RECRUITING · Phase 3
-
Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial
COMPLETED · Phase 3
-
Advancing Discussions Using a Video-based Support Tool About End-of-life Care
RECRUITING · NA
-
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
RECRUITING · NA
-
Pediatric and Caregiver Traumatic Stress Intervention (PACTS)
RECRUITING · NA
-
Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI